COVID-19 Spike Generating Therapeutics and Pregnancy - What to Do?

Two Points of View.

Advice #1: No. Avoid at All Cost.

1. The Canadian COVID Care Alliance issued this cautionary video.

   https://rumble.com/v32thny-are-the-covid-19-mrna-vaccines-safe-for-pregnant-and-breastfeeding-women.html

   

   https://www.canadiancovidcarealliance.org/

2. Former Pfizer executive, Michael Yeadon agrees.

Question: Is this advice supported by Warning Signals in the US Government Vaccine Adverse Event Reporting System (VAERS)?

Answer: Yes it is.

VAERS has 2.6 Times more Adverse Events in Women Ages 18-49 in <3 years for C19 “Vaccines” than the number of AEs in 18-49 year old women for all vaccines during the 19 previous years.

Deaths, Life Threatening Illness and Permanent Disability increased over 2-3 times for Women ages 18-49 in Less than 3 years compared with 19 years for all other vaccines.

From VAERS: C19 “vaccines” in women of reproductive age, accessed August 1, 2023, US and Territories.

Miscarriages also spiked with spike drugs,

As did a host of other female reproductive organ dysfunctions.

Perhaps this happens because the drug targets the female reproductive system. (Pfizer Confidential Document 2.4.)

LNP/mRNA concentrates in ovaries much more than it does compared with testes.

(https://robertchandler.substack.com/publish/posts/detail/55202386?referrer=%2Fpublish%2Fposts)

The uterus is infiltrated with activated lymphocytes after LNP/nRNA treatment.

Section of uterus from Dr. Burkhardt’s collection showing lymphocytic infiltration.

Advice #2: Yes. Safe and Effective Says the US Government and The Medical Establishment. Go ahead and get an Injection.

From the CDC,

The following is a joint statement from the

American College of Obstetricians and Gynecologists |

American Academy of Family Physicians |

American Academy of PAs |

American Academy of Pediatrics |

American Association of Nurse Practitioners |

American College of Nurse-Midwives |

American College of Osteopathic Obstetricians & Gynecologists |

American College of Physicians |

American Pharmacists Association |

Association of Immunization Managers |

Association of State and Territorial Health Officials |

Association of Women’s Health, Obstetric and Neonatal Nurses |

Infectious Diseases Society of America |

Infectious Diseases Society for Obstetrics and Gynecology |

National Association of Chain Drug Stores |

National Association of County & City Health Officials |

National Association of Nurse Practitioners in Women's Health |

National Foundation for Infectious Diseases |

National Hispanic Medical Association |

North American Society for Pediatric and Adolescent Gynecology |

Society for Maternal-Fetal Medicine |

Society of OB/GYN Hospitalists |

Vaccinate Your Family

Evidence cited: [null]

However,

1. The drugs were not tested in pregnant women.

2. HCG (human chorionic gonadatropin) data from the Phase 3 trial have not been released.

3. The control group in the clinical trials was unblinded at two months, 22 months before they should have been for an experimental drug.

4. No active scientific prospective surveillance of pregnant women has been reported.

5. The required post marketing prospective study by Pfizer was completed a year ago and no results have been released. The study was underpowered and did not recruit first trimester pregnant women.

Conclusions:

The safety data do not support the official recommendation for pregnant women to have a COVID-19 LNP/mRNA product.

There is no amount of time before pregnancy that the drug can be considered safe given the very long duration of action of these novel products.